References
Key articles
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Full text
British Association for Sexual Health and HIV. UK national guideline for the management of pelvic inflammatory disease. Jan 2019 [internet publication].Full text
Ross J, Guaschino S, Cusini M, et al. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018 Feb;29(2):108-14.Full text Abstract
American College of Radiology. ACR appropriateness criteria: acute pelvic pain in the reproductive age group. 2023 [internet publication].Full text
Reference articles
1. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Full text
2. Grodstein F, Rothman KJ. Epidemiology of pelvic inflammatory disease. Epidemiology. 1994 Mar;5(2):234-42. Abstract
3. Crossman SH. The challenge of pelvic inflammatory disease. Am Fam Physician. 2006 Mar 1;73(5):859-64.Full text Abstract
4. Sutton MY, Strenberg M, Zaidi A, et al. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States 1985-2001. Sex Trans Dis. 2005 Dec;32(12):778-84. Abstract
5. Price MJ, Ades AE, Welton NJ, et al. Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England. Epidemiol Infect. 2017 Jan;145(1):208-15.Full text Abstract
6. Kreisel K, Torrone E, Bernstein K, et al. Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age - United States, 2013-2014. MMWR Morb Mortal Wkly Rep. 2017 Jan 27;66(3):80-3.Full text Abstract
7. Goller JL, De Livera AM, Fairley CK, et al. Population attributable fraction of pelvic inflammatory disease associated with chlamydia and gonorrhoea: a cross-sectional analysis of Australian sexual health clinic data. Sex Transm Infect. 2016 Nov;92(7):525-31.Full text Abstract
8. Price MJ, Ades AE, Welton NJ, et al. Proportion of pelvic inflammatory disease cases caused by Chlamydia trachomatis: consistent picture from different methods. J Infect Dis. 2016 Aug 15;214(4):617-24.Full text Abstract
9. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362-6.Full text Abstract
10. Dayan L. Pelvic inflammatory disease. Aust Fam Physician. 2006 Nov;35(11):858-62. Abstract
11. National STD Curriculum. Self-study STD module: PID. Feb 2017 [internet publication].Full text
12. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ. 2004 Jun;82(6):454-61.Full text Abstract
13. Ness RB, Randall H, Richter HE, et al. Pelvic Inflammatory Disease Evaluation and Clinical Health Study Investigators. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. 2004 Aug;94(8):1327-9.Full text Abstract
14. McCormack, WM. Pelvic inflammatory disease. N Engl J Med. 1994 Jan 13;330(2):115-9. Abstract
15. Scholes D, Daling JR, Stergachis AS. Current cigarette smoking and risk of acute pelvic inflammatory disease. Am J Public Health. 1992 Oct;82(10):1352-5.Full text Abstract
16. Marchbanks PA, Lee NC, Peterson HB. Cigarette smoking as a risk factor for pelvic inflammatory disease. Am J Obstet Gynecol. 1990 Mar;162(3):639-44. Abstract
17. Simms I, Stephenson JM. Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? Sex Transm Infect. 2000 Apr;76(2):80-7.Full text Abstract
18. Simms I, Stephenson JM, Mallinson H, et al. Risk factors associated with pelvic inflammatory disease. Sex Transm Infect. 2006 Dec;82(6):452-7.Full text Abstract
19. Henderson JT, Senger CA, Henninger M, et al. Behavioral counseling interventions to prevent sexually transmitted infections: updated evidence report and systematic review for the US preventive services task force. JAMA. 2020 Aug 18;324(7):682-99.Full text Abstract
20. Public Health England. Health matters: preventing STIs. Aug 2019 [internet publication].Full text
21. Molina JM, Charreau I, Chidiac C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308-17.Full text Abstract
22. Luetkemeyer AF, Donnell D, Dombrowski JC, et al. Postexposure doxycycline to prevent bacterial sexually transmitted infections. N Engl J Med. 2023 Apr 6;388(14):1296-306.Full text Abstract
23. Molina JM, Bercot B, Assoumou L, et al. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. Lancet Infect Dis. 2024 Oct;24(10):1093-104. Abstract
24. Bachmann LH, Barbee LA, Chan P, et al. CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United States, 2024. MMWR Recomm Rep. 2024 Jun 6;73(2):1-8.Full text
25. US Preventive Services Task Force. Screening for chlamydia and gonorrhea: US Preventive Services Task Force recommendation statement. JAMA. 2021 Sep 14;326(10):949-56.Full text Abstract
26. British Association for Sexual Health and HIV. UK national guideline for the management of pelvic inflammatory disease. Jan 2019 [internet publication].Full text
27. Evans D, Goldstein S, Loewy A, et al. SOGC Committee Opinion no. 385 - indications for pelvic examination. J Obstet Gynaecol Can. 2019 Aug;41(8):1221-34. Abstract
28. Peipert JF, Ness RB, Blume J, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol. 2001 Apr;184(5):856-63; discussion 863-4. Abstract
29. Pinto-Sander N, Soni S. Mycoplasma genitalium infection. BMJ. 2019 Oct 18;367:l5820. Abstract
30. Jensen JS, Cusini M, Gomberg M, et al. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022 May;36(5):641-50.Full text Abstract
31. Horrow MM. Ultrasound of pelvic inflammatory disease. Ultrasound Q. 2004 Dec;20(4):171-9. Abstract
32. Vandermeer FQ, Wong-You-Cheong JJ. Imaging of acute pelvic pain. Clin Obstet Gynecol. 2009 Mar;52(1):2-20. Abstract
33. Yudin MH, Hillier SL, Wiesenfeld HC, et al. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol. 2003 Feb;188(2):318-23. Abstract
34. Ross J, Guaschino S, Cusini M, et al. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS. 2018 Feb;29(2):108-14.Full text Abstract
35. Molander P, Sjoberg J, Paavonen J, et al. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol. 2001 Mar;17(3):233-8. Abstract
36. American College of Radiology. ACR appropriateness criteria: acute pelvic pain in the reproductive age group. 2023 [internet publication].Full text
37. Balthazar EJ, Birnbaum BA, Yee J, et al. Acute appendicitis: CT and US correlation in 100 patients. Radiology. 1994 Jan;190(1):31-5. Abstract
38. Low N, Bender N, Nartey L, et al. Effectiveness of chlamydia screening: systematic review. Int J Epidemiol. 2009 Apr;38(2):435-48.Full text Abstract
39. Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med. 2001;20:95-107. Abstract
40. Roberts TE, Robinson S, Barton PM, et al. Cost effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of chlamydia screening studies (ClaSS) project. BMJ. 2007 Aug 11;335(7614):291.Full text Abstract
41. Taylor BD, Haggerty CL. Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges. Infect Drug Resist. 2011 Jan;2011(4):19-29.Full text Abstract
42. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010 Apr 8;340:c1642.Full text Abstract
43. Price MJ, Ades AE, De Angelis D, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013 Aug 1;178(3):484-92.Full text Abstract
44. Savaris RF, Fuhrich DG, Maissiat J, et al. Antibiotic therapy for pelvic inflammatory disease. Cochrane Database Syst Rev. 2020 Aug 20;(8):CD010285.Full text Abstract
45. Boukes FS, Dekker JH, Wiersma TJ, et al. Nederlands Huisartsen Genootschap. Summary of the practice guideline 'Pelvic inflammatory disease' (first revision) from the Dutch College of General Practitioners [in Dutch]. Ned Tijdschr Geneeskd. 2007 Mar 31;151(13):753-6. Abstract
46. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3).Full text Abstract
47. Royal College of General Practitioners/British Association for Sexual Health and HIV. Sexually transmitted infections in primary care 2013 (RCGP/BASHH). 2013 [internet publication].Full text
48. American College of Obstetricians and Gynecologists. Expedited partner therapy. Jun 2018 [internet publication].Full text
49. Ross J. Pelvic inflammatory disease. Clin Evid. 2006 Jun;(15):2176-82. Abstract
50. Terao M, Koga K, Fujimoto A, et al. Factors that predict poor clinical course among patients hospitalized with pelvic inflammatory disease. J Obstet Gynaecol Res. 2014 Feb;40(2):495-500. Abstract
51. Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess. Clin Obstet Gynecol. 2012 Dec;55(4):893-903. Abstract
Use of this content is subject to our disclaimer